THURSDAY, Feb. 6, 2025 -- Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell...

A new personalized cancer vaccine has shown encouraging results in preventing the return of kidney cancer after surgery. Researchers at Dana-Farber...

Researchers at the Terasaki Institute for Biomedical Innovation have developed an innovative delivery system that could significantly improve the...

A revolutionary personalized cancer vaccine developed by Russia’s Gamaleya Research Institute of Epidemiology and Microbiology is expected to...

A world-first clinical trial is hoping a successful brain cancer drug can help people fighting one of the deadliest forms of breast cancer.

A world-first clinical trial is hoping a successful brain cancer drug can help people fighting one of the deadliest forms of breast cancer.

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the...

FRIDAY, Feb. 7, 2025 -- Giving patients with a common form of breast cancer an immunotherapy drug before surgery appears to boost outcomes, a new...

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed a computer model to help...

DALLAS, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Gradalis, Inc., a clinical-stage biotechnology company developing personalized anti-cancer therapies, today...